IQVIA Holdings, Inc. Common Stock (NY:IQV)

Nvidia's (NASDAQ: NVDA) recent stock performance has been a whirlwind of soaring highs and sharp corrections, acting as a potent barometer for the broader Wall Street landscape as of November 11, 2025....

Nvidia's AI Reign: A $5 Trillion Bellwether Shaping Wall Street's Fortunes

November 11, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

3 Cash-Producing Stocks We Approach with Caution

November 10, 2025

Recent third-quarter (Q3) 2025 corporate earnings have painted a complex yet largely positive picture for North American equity markets. While robust performances from key sectors, particularly...

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

Corporate Earnings Fuel Market Gains, But Mixed Results Hint at Underlying Volatility

November 07, 2025

Q3 Earnings Highs And Lows: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

Topics Artificial Intelligence Earnings Economy

November 06, 2025

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including IQVIA (NYSE:IQV) and its...

Dr. William G. Kaelin Jr. joins IQVIA Board of Directors

November 05, 2025

From IQVIA

IQVIA's third quarter results reflected stable operational execution, with revenue and profit slightly ahead of Wall Street expectations. Management identified robust free cash flow generation and a...

IQVIA’s Q3 Earnings Call: Our Top 5 Analyst Questions

November 04, 2025

Shares of clinical research company IQVIA (NYSE: IQV) fell 2.5% in the afternoon session after TD Cowen downgraded its rating on the stock from Buy to Hold. The firm cited valuation concerns as the...

Topics Earnings

Why IQVIA (IQV) Shares Are Trading Lower Today

November 03, 2025

This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday ↗

October 29, 2025

Via Benzinga

IQV Q3 Deep Dive: Clinical Research Demand and AI Initiatives Drive Steady Growth

October 29, 2025

Clinical research company IQVIA (NYSE: IQV) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 5.2% year on year to $4.1 billion. The company expects the full year’s...

As of October 2025, Nvidia (NASDAQ: NVDA) stands on the precipice of a historic $5 trillion market valuation, a testament to its unparalleled dominance in the artificial intelligence (AI) and...

Topics Artificial Intelligence

Nvidia Rockets Towards $5 Trillion Valuation, Reshaping the Global Tech Landscape

October 28, 2025

Tech stocks hit new highs as the Nasdaq 100 rallies 0.7% midday. Investors eye a Fed rate cut, Trump-Xi meeting, and major tech earnings.

Topics Artificial Intelligence Economy

Nasdaq 100 Hits 26,000, Gold Falls Below $4,000: What's Moving Markets Tuesday? ↗

October 28, 2025

Via Benzinga

Topics Economy

IQVIA HOLDINGS INC (NYSE:IQV) Reports Q3 2025 Earnings Beat and Positive Market Reaction ↗

October 28, 2025

IQVIA Q3 2025 earnings beat EPS estimates with $3.00 per share. Revenue grew 5.2% to $4.10B. The company reaffirmed its strong full-year 2025 guidance.

Via Chartmill

Topics Earnings

IQVIA (NYSE:IQV) Beats Q3 Sales Expectations

October 28, 2025

Clinical research company IQVIA (NYSE: IQV) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 5.2% year on year to $4.1 billion. The company expects the full year’s...

IQVIA Reports Third-Quarter 2025 Results

October 28, 2025

From IQVIA Holdings Inc.

Clinical research company IQVIA (NYSE: IQV) will be reporting earnings this Tuesday morning. Here’s what investors should know.

IQVIA (IQV) Reports Earnings Tomorrow: What To Expect

October 26, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...

Topics Artificial Intelligence

3 Healthcare Stocks Walking a Fine Line

October 24, 2025

Topics Stocks

IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025

October 21, 2025

From IQVIA

Shares of clinical research company IQVIA (NYSE: IQV) jumped 3.6% in the afternoon session after Bank of America raised its price target on the company's shares to $230 from $215. The adjustment from...

Why IQVIA (IQV) Stock Is Trading Up Today

October 20, 2025

IQVIA has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.8%. The stock now trades at $200.20, marking a 39.8% gain. This was partly thanks to its solid...

Topics Artificial Intelligence

3 Reasons to Sell IQV and 1 Stock to Buy Instead

October 10, 2025

Market Minute: Fed's Dovish Pivot Amidst Softening Labor Market – What It Means for Investors

Topics Stocks

This Tractor Supply Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

October 09, 2025

Via Benzinga

Looking Into IQVIA Holdings Inc's Recent Short Interest ↗

October 07, 2025

Via Benzinga

October 04, 2025

The U.S. labor market is flashing clear signs of weakness as of October 2025, prompting a significant shift in the Federal Reserve's monetary policy. With unexpected job losses and a rising...

San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic...

Topics Artificial Intelligence Bonds Economy

Demystifying IQVIA Hldgs: Insights From 8 Analyst Reviews ↗

October 02, 2025

Via Benzinga

Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI

October 01, 2025

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs.

Topics Artificial Intelligence Intellectual Property

Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years ↗

October 01, 2025

Via Benzinga

Topics Government

Why IQVIA (IQV) Stock Is Trading Up Today

October 01, 2025

Shares of clinical research company IQVIA (NYSE: IQV) jumped 6.3% in the afternoon session after the company, in partnership with GSK, announced a major update to its Vaccine Track data tool for...

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

Topics Government

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Topics Artificial Intelligence Economy Government

IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025

September 30, 2025

From IQVIA Holdings Inc.